Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.362NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GK.2.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DN.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HK.3.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.4.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BW.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.312NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.13.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.220NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.142NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.523NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.36.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-19760.5South Korea
B.1.1.418NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.389NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.53NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.363NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HV.1.7NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.405NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.282NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.228NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.174NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.88 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BG.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
KN.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.61NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.37NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XASNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.3.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BE.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CH.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.86NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.543NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.139NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.31NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.221NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.362NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.265NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.585NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.351NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.36.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.383NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.40NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.95 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.189NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used